<DOC>
	<DOCNO>NCT00526968</DOCNO>
	<brief_summary>The purpose study investigate neurophysiological change follow single dos EVT 101 use fMRI rest cognitive task young healthy male subject .</brief_summary>
	<brief_title>The Effects Novel NMDA NR2B-Subtype Selective Antagonist , EVT 101 , Brain Function</brief_title>
	<detailed_description />
	<criteria>Healthy Male volunteer Body Mass Index 19 29 Subjects receive prescribed medication within 5 half live 14 day first dose administration whichever longer Subjects receive prescribed CNS medication medication know chronically alter drug absorption elimination process within 30 day first dose administration Participation clinical trial investigational drug within past 4 month market drug within past 3 month History allergy NMDA antagonists clinically significant drug allergy Supine blood pressure heart rate high 140/90 mmHg 90 bpm respectively low 80/40 mmHg 40 bpm Consumption 21 unit alcohol per week history alcoholism drug/chemical abuse Smokers 5 cigarette equivalent per day Subjects complete neuropsychological test battery Any clinically significant health deficit</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>